Natco Pharma Limited - SpicyIP

• ..

Natco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034.

Tclang.ana, INDIA. 'Jel: +9140 23547532, Fax: +9'1 40 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in

-2--Please find enclosed the copy of the swift details sent as per the sender's reference no.004MISC01518965G from our Banker INDUSIND BANK LIMITED to the BANK OF NEW YORK, MELLON, PITSBURGH/ PA, USA. Please also find enclosed a Chartered Accountant Certificate about the sales made for the period for the product.

Kindly acknowledge the receipt oft he same.

Thanking you,

Yours faithfully, For NATCO Pharma Limited

k~~ M.AOJNARA YANA COMPANY SECRETARY & VICE PRESIDENT (LEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to:

(I} The Controller General of Patents, Designs and Trademarks - For favor of information BhoudhikSampada Bhavan and records. Near Antop Hill Head Post Office, S.M. Road, Antop Hill, Mumbai- 400 037.

{ii) The Deputy Registrar - For favor of information and records. lntellectuaJ Property Appellate Board Annex-1, Guna Complex, II Floor 443, Anna Salai1 Teynarnpet CHENNAI- 600 018.

{Iii} Bayer Corporation - For favor of information and records. 100, Bayer Road, Pittsburgh, PA 15205-9741, USA.

(iV} Rajeshwarl & Associates - For favor of information and records. S-208, Lower Ground Floor Near lNG Vysya Bank, Panchsheel Park NEW DELHI -110 017.

,~&~ C oCC.oL"L~~ • .,o~~•>•'ffi~w~~>'cl::=t""+. '''~'~CC. --~·CL•'·'~

~

'

::~ ,•J <:

1 ·-- -· -

'

KOWTHA & CO CHARTERED ACCOUNTANTS

Service Tax No. 22/72/CNl53/98

Hyd. Branch : Plot No. 116 7, Rd. 54, Jubilee Hills, Hyderobad - 500 033. Phone : 040-65695432 Mobile : 9849441118 Email : [email protected]

Dote : ............................... .

TO WHOMSOEVER IT MAY CONCERN

TIDS IS TO CERTIFY THAT, we have certified the records of MIS. NATCO PHARMA LIMITED, having its Registered Office at NATCO House, Road No.2 Banjara Hills, Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENAT 200mg Tablets 120's made by the said Company during the period of April, 2015 to June, 2015.

Based on the verification of the records, infonnation and the explanation given by the Company, we hereby certify that the Company has made the following sales of SORA FEN AT 200mg Tab 120's during the period under review.

SI. No. Month

1. April, 2015

2 May, 2015

3 June, 2015

Total

Net Sales Made by the Company

No. of Bottles Sold (120 tab. i

Pack

3992

4036

5863

13891

Value in Rs.

24307847

24575769

35700628

84584244

The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory license for manufacture of a product owned by M/s. Bayer Corporation and not on account of any technical or financial collaboration. The limits of Royalty fixed under the Income Tax Act I FEMA therefore, do not apply to this payment. This payment is being made on the orders of the lntellectual Property Appellate Board.

Date : July 13, 2015

For KOWTHA & Co. Chartered Accountants

M. N~.-~,9~842

~-'\ ' ~ ~ \cJR \ G. SUJATA

i l Partner I I ,,

Head Office : 26-22-21, Mudunuruvori Street, Gandhi Nagar, Vijayawada - 520 003. Phone : 0866-5563440, 0866-2573440, Fax : 0866-2570960

--------------------- Instance Type and Transmission ------------Notification (Transmission) of Original sent to SWIFT (ACK) Network Delivery Status : Network Ack Priority/Delivery : Normal Message Input Reference : 2002 1507141NDBINBBAHYB9993884291

--------------------------- Message Header -------------------------Swift Input :FIN 103 Single Customer Credt Transfer Sender : INDBINBBHYB

INDUSIND BANK LIMITED (HYDERABAD, S.P. ROAD) HYDERABADIN

Receiver : MRMDUS33XXX HSBC BANK USA, N.A. NEW YORK,NY US

MUR: M78921 --------------------------- Message Text -------------------------

20: Sender's Reference 004MISC015189656

23B: Bank Operation Code CRED

32A: Val Dte/Curr/lnterbnk Settld Amt Date : 14 July 2015 Currency : USD (US DOLLAR) Amount #83380, 76#

50K: Ordering Customer-Name & Address /0004209161 060 NATCO PHARMA LIMITED NATCO HOUSE, ROAD NO 2, BANJARA HILLS HYDERABAD , INDIA

53A: Sender's Correspondent- Fl BIC /000048283 INDBINBBXXX INDUSIND BANK LIMITED MUMBAI IN

57 A: Account With Institution- Fl BIC MELNUS3PXXX

:.>if/~

---:\ r

THE BANK OF NEW YORK MELLON PITTSBURGH,PA US

59: Beneficiary Customer-Name & Addr /0065525 BAYER CORPORATION 100, BAYER ROAD, PITTSBURG, PA 15205-9741, USA

70: Remittance Information ROYAL Y PAYMENT

71A: Details of Charges OUR

-------------------------- Message Trailer -----------------------{CHK:896ACFA2A980} PKI Signature: MAC-Equivalent

--------------------------- Interventions -------------------------Category : Network Report Creation Time: 14/07/15 20:02:22 Application :SWIFT Interface Operator : SYSTEM Text {1:F211NDBINBBAHYB9993884291}{4:{177:1507142002}{451:0}{108:M78921}}

,, ' ·'·~--.

·,\ -~.\_'

.!'

,A:/ .. c_ .. 1


Tel.angana. INDIA. Tel: +9140 23547532, Fax: +9140 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in

Bayer Corporation 141h October, 2015 100, Bayer Road, Pittsburgh, PA 15205-9741, USA. A<fdressfor Service In India PERFEXtO LEGAL, 9655, Sector-c, Pocket 9, Vasant Kunj New Delhi- 110 070.

Kind attn: Mr. Sanjay Kumar, Counsel for the Patentee

Respected,Sir,

Sub: Payment of Royalty on Net Sales of Soraferiib made by the Company for the period July, 2015 to September, 2015- Reg.

Ref: 1. Order dated 9111 March 2012 of the Controller General of Patents, Design and Trademarks. 2. Intellectual Property Appellate Board Order no.45/2013 in OA/35/2012/PT/MUM dt.41h March, 2013

"'"'"' With reference to the above subject we would like to state the following:

We have remitted the royalty amount for the period July, 2015 to September, 2015 as per the Bank details provided in your letter no.SKR/ASY/Appeal dt.61h September, 2012 via electronic swift remittance on 13-10-2015. The royalty payment details are as follows:

Particulars Amount In Rs./ us $ (Fractions were Rounded off wherever required}

(vii) Net Sales of SOrafenat for the period July, 2015 to 5,18,00,313 September, 2015 in Rupees

(viii) Royalty amount as per Reference No.2 @7% in Rupees 36,26,022 (ix) *Withholding Tax @10.506% on Royalty amount in Rs. 3,80,950 {x} Net amount of Royalty In Indian Rupees (ii)- (iii) 32,45,072 (xi) Conversion Rate as on 14-7-2015 from Indian Rupees 64.92

to us Dollar($) (xii) Royalty amount in US$ 49,985.71

.. 2

JU,M !C ,£ StML&MZ. .. Utd h •• ,


Telangana, INPIA. Tel: +9140 23547532, Fax: +9140 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in

-2-

Please find endosed the copy of the swift details sent as per the sender's reference no.004MISC015202354 from our Banker INDUSIND BANK LIMITED to the BANK OF NEW YORK, MEUON, PITSBURGH, PA, USA. Please also find enclosed a Chartered Accountant Certificate about the sales made for the said period for.the product.

Kindly acknowledge the receipt of the same.

Thanking you,

Yours falthfulfy, For NJl.TCO Pharma Limited

M~~'""{ M.ADINARA YANA COMPANY SECRETARY & VICE PRESIDENT {LEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to: (li) The ControJJer General of Patents, Designs and Trademarks - For favor of information

and records. Shoudhik Sampada Bhavan NearAntop HiUHead PostOfflce, S.M.Road, Antop Hill, Mumbai- 400 037.

(II) The Deputy Registrar Intellectual Property Appellate Board Annex-1, Guna Complex, II Floor 443, Anna Salal, Teynampet CHENNAI~ 600 018.

(iii) Bayer Corporation 100, Bayer Road, Pittsburgh, PA 15205•9741, USA.

(lv) Rajeshwarl & Associates S-208, lower Ground Floor Near lNG Vysya Bank, Panchsheel Park NEW DELHI-110 017.

- For favor of information and records.



~\

r

--------------------- Instance Type and Transmission-------------Notification (Transmission) of Original sent to SWIFT (ACK) Network Delivery Status : Network Ack Priority/Delivery : Normal Message Input Reference : 2345 1510131NDBINBBAHYB0086959945

--------------------------- Message Header -------------------------Swift Input : FIN 103 Single Customer Credt Transfer Sender : INDBINBBHYB


Receiver : MRMDUS33XXX HSBC BANK USA, N.A. NEW YORK, NY US

MUR: M71089 -------------------------- Message Text ---------------------------



32A: Val Dte/Currllnterbnk Settld Amt Date : 13 October 2015 Currency : USD (US DOLLAR) Amount #49985,71#

50K: Ordering Customer-Name & Address /200000319957 NATCO PHARMA LIMITED NATCO HOUSE, ROAD NO 2, BANJARA HILLS HYDERABAD , INDIA

53A: Sender's Correspondent- Fl BIG /000048283 INDBINBBXXX INQUSIND BANK LIMITED MUMBAI IN

57 A: Account With Institution- Fl BIG MELNUS3PXXX

\.'\~ .·\

\ . i

.\J


59: Beneficiary Customer-Name & Addr /0065525 BAYER CORPORATION 100, BAYER ROAD, PITTSBURGH, PA 15205-97 41 , USA

70: Remittance Information ROYALTY SERVICES


--------------------------- Message Trailer------------------------{CHK:3F2EB846EAEB} PKI Signature: MAC-Equivalent

-------------------------- Interventions ------------------------Category : Network Report Creation Time: 13/10/15 23:45:17 Application : SWIFT Interface Operator : SYSTEM Text {1 :F211NDBINBBAHYB0086959945}{4:{177:151 0132345}{451 :0}{1 08:M71 089}}

-., \

··,')-). ' --

\

\_\ry/ f'0WTHA & CO &RTERED ACCOUNTANTS

Hyd, Branch : Plot No. 1 7 6 7, Rd. 54, Jubilee Hills, Hyderobod - 500 033. Phone : 040-65695432 Mobile : 9849441118 Email : [email protected]

Service Tax No.: AAGFK1590FST001

I I

TillS IS TO CERTIFY THAT. we have certified the records of M/S. NATCO PHARMA LIMITED, having its Registered Office at NATCO House, Road No.2 Banjara Hills,

Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand

name SORAFENAT 200mg Tablets 120's made by the said Company during the period of July, 2015 to September, 2015.

Based on the verification of the records, information and the explanation given by the

Company, we hereby certify that the Company has made the following sales of SORAFENAT 200mg Tab 120's during the period under review.

i Month

'-------------------·······! l Net Sales Made by the Company

j___ __________________ --,---------1 i No. of Bottles Sold (120 tab. :

Value in Rs ' Pack ..

I I

---~----------· ························--~~-·-------···-~

1. July, 2015 2838 i 17280979 1

2 August~ 2015 2153 13109918 •u--.-n-• --

3 September, 2015 3516 21409416

Total 8507 I 51800313 I ' I

·-· ~------··-

The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory

license for manufacture of a product owned by M/s. Bayer Corporation and not on account of

anv technical or financial collaboration. The limits of Rovalty fixed under the Income Tax Act - -1 FEMA therefore, do not apply to this payment. This payment is being made on the orders of

the Intellectual Property Appellate Board.

Date : September 12, 2015 Place : Hyderabad

For KC>•tvT:-1/\ f:~ Cc Chartered . .u.ccou ntants

M ND. ~MS42 ,\~ :) :.:y _l

f.\ G SUJATl>..

Partner

J

Head Office: 26-22-21, Mudunuruvari Street, Gandhi Nagar, Vijayawoda- 520 003. Phone: 0866-5563440, 0866-2573440, Fox : 0866-2570960

\\) .,_ .--·

. ,···/


Thlangana, INDIA. Tel: +9140 23547532, Fax: +91 40 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in

Bayer Corporation 131h January, 2016 100, Bayer Road, Pittsburgh, PA 15205-9741, USA. Address for Senllce Jn India PERFEXIO LEGAL, 9655, Sector-C, Pocket 9, Vasant Kunj New Delhi-110 070.

Kind attn: Mr. Sanjay Kumar, Counsel for the Patentee

Respected Sir,

Sub: Payment of Royalty on Net Sales of Sorafenib made by the Company for the period October, 2015 to December, 2015- Reg.

Ref: i. Order dated gth March 2.012 of the Controller General of Patents, Design and Trademarks. 2.1ntellectual Property Appellate Board Order no.45/2013 in OA/35/2012/PT/MUM dt.4111 March, 2013

*** With reference to the above subject we would like to state the following:

We have remitted the royalty amount for October, 2015 to December, 2015 as per the Bank details provided in your letter no.SKR/ASY/Appeal dt.61

h September, 2012 received via electronic swift remittance on 12,01-2016. The royalty payment details are as follows:

(i)

(ii)

(iii) {iv) (v)

(vi)

Particulars

Net Sales of Sorafenat for the period October, 2015 to December, 2015 in Rupees Royalty amo.unt as per Reference No.2 @7% in Rupees *Withholding Tax @10.506% on Royalty amount in Rs. Net amount of Royalty in Indian Rupees (ii)- {iii) Conversion Rate as on 12-1-2016 from Indian Rupees to us Dollar{$) Royalty amount in l)S $

.. ,o. ' \rJ/

·~·"-··· ··'. 1 . .

Amount in Rs./ US $ (Fractions were Rounded off wherever required)

7,20,29,972 I

50,42,098

5,29,723 45,12,375

66.87

67,479.81

.,, ;· .. JI~

:!;y:..~ ~.tiJ'"

\\~ Natco Pharma Limited

Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills. Hyderabad • 500034. Telangana, INDIA. Tel: +91 40 23547532, J:oax; +9140 23548243

CIN: L24230TG1981PLC003201, WJ..VW.natcopharma.co.in

Please firid enclosed the copy of the swift details sent as per the sender's reference no.004MISC016218326 from our Banker INDUSIND BANK LIMITED to the HSBC BANK NEW YORK, USA.

Please also find enclosed the Chartered Accountant Certificate about the product sales made during the said period.


Thanking you,


. ~\l\\:Y• r-"~"1' '(V M.AOINARAYANA

COMPANY SECRETARY & VICE PRESIDENT (LEGAl & CORP. AFFAIRS)

Encl: a. a.

C:C.to: (I) The Controller General of Patents, Designs and Trademarks- For favor of information Bhoudhik Sampada Bhavan and records. Near Antop Hill Head Post Office, S.M.Road, Antop Hill, Mumbai- 400 037.

(ii) The Deputy Registrar Intellectual Property Appellate Board Annex-1, Guna Complex, II Floor 443, Anna Salai~_ Teynampet CHENNAI- 600 018.

(iii) Bayer Corporation 100, Bayer Road, Pittsburgh, PA 15205-9741, USA.

(iv) Rajeshwarl & Associates S-208, Lower Ground Flo.or

Near lNG Vysya Bank, Panchsheel Park NEW DElHI-110 017.

-For favor of information and records.


• For favor of information and records.

2

,---\ (}

r

--------------------- Instance Type and Transmission -------------Notification (Transmission) of Original sent to SWIFT (ACK) Network Delivery Status : Network Ack Priority/Delivery : Normal Message Input Reference :2120 1601121NDBINBBAHYB0170036910

-------------------------- Message Header -----------------------Swift Input :FIN 103 Single Customer Credt Transfer Sender : INDBINBBHYB



MUR: M85686 --------------------------- Message Text -------------------------



32A: Val Dte/Curr/lnterbnk Settld Amt Date : 12 January 2016 Currency : USD (US DOLLAR) Amount #67479,81#

50K: Ordering Customer-Name & Address /200000319957 NATCO PHARMA LIMITED NATCO HOUSE, ROAD NO 2, BANJARA HILLS HJDERABAD , INDIA

53A: Sender's Correspondent- Fl BIC /000048283 INDBINBBXXX INDUSIND BANK LIMITED MUMBAI IN

57 A: Account With Institution - Fl BIC MELNUS3PXXX


59: Beneficiary Customer-Name & Addr /006 5525 BAYER CORPORATION 100 BAYER ROAD PITTSBURGH PA 15205-97 41 USA

70: Remittance Information ROYALTY PAYMENT OCT 2015 TO DEC 2015


--------------------------- Message Trailer -----------------------{CHK:73EE43BDF837} PKI Signature: MAC-Equivalent

--------------------------- I nte rve nti on s -------------------------Category : Network Report Creation Time: 12/01/16 21:20:47 Application :SWIFT Interface Operator : SYSTEM Text {1 :F211NDBINBBAHYB0170036910}{4:{177:1601122120}{451 :0}{108:M85686}}

\,. ~

.,~

:}

JW'OWTHA & CO ~ARTEAED ACCOUNTANTS

_,/' ,, "' ' ' ' _.,.. ~

~ I

'. ' Hyd. Branch : Plot No. 7 7 67, Rd. 54, Jubilee Hills, Hyderabod- 500 033. Phone : 040-65695432

Service Tax No.: AAGFK 1590FSTOO 1 Mobile : 9849441118 Email : [email protected]

Date ; ................................... .


TIDS IS TO CERTIFY THAT, we have certified the records ofM/S. NATCO PHARMA LIMITED, having its Registered Office at NA TCO House, Road No.2 Banjara Hills,

Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENAT 200mg Tablets 120's made by the said Company during the period of October, 2015 to December, 2015.

Based on the verification of the records, information and the explanation given by the Company, we hereby certify that the Company has made the following sales of SORAFENAT 200mg Tab 120's during the period under review.

f SI. No. Month Net Sales Made by the Company

No. of Bottles Sold (120 tab. I I

Pack Value in Rs.

1. I October, 2015 3208 19533902

2 November, 2015 4979 30317828

3 . , December, 2015 3644 22178242!

TotaJ I

11831 72029972

The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory license for manufacture of a product owned by M/s. Bayer Corporation and not on account of any technical or financial collaboration. The limits of Royalty fixed under the Income Tax Act

I FEMA therefore, do not apply to this payment. This payment is being made on the orders of the Intellectual Property Appellate Board.

Date : January 12, 2016 Place : Hyderabad

Head Office: 26-22-21, Mudunuruvari Street, Gandhi Nagar, Vijoyawada - 520 003. Phone: 0866-5563440, 0866-2573440, Fax: 0866-2570960

Natco Pharma Limited Regd. Off. : 'NATCO HOUSE:, Road No. 2, Banjara Hills, Hyderabad · 5000:3·+.

Telangann, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243 C1N: l;2:4230TG1981PLC003201, \ltww.natcopharma.co.in

Bayer Corporation 100, Bayer Road, Pittsburgh,

PA 15205·9741, USA. Address-for Service In India PERFEXIO LEGAL, 9655, Sector-C, Pocket9, Vasant Kunj New Delhi- 110 070.

18th April, 2016

Kind Attn: Mr. Sanjay Kumar, Counsel for the Patentee

Respected Sir,

Sub: Payment of Royalty on Net Safes of Sorafenib made by the Company for the period January, 2016 to March, 2016- Reg.

Ref: 1. Order dated gth March 2012 of the Controller General of Patents, Design and Trademarks. 2. Intellectual Property Appellate Board Order no.45/2013 in OA/35/2012/PT/MUM dt.41h March,

2013


We have remitted the royalty amount for January, 2016 to March, 2016 as per the Bank details provided in your letter noSKR/ASY/Appeal dt.6~h September, 2012 received via electronic swift remittance on

13-04-2016. The royalty payment details are as follows:

(i)

(ii)

(iii) (lv) (v)

(vi)

IO!:fN'I· ... (,,,

Particulars

Net Sales of Sorafenat for the period January, 2016 to March, 2016 in Rupees Royalty amount as per Refere.nce No.2 @7% in Rupees *Withholding Tax @10.506% on Royalty amount in Rs.

Net amount of Royalty In Indian Rupees (ii)- (iii) Conversion Rate as on 13-4-2016 from Indian Rupees to US Dollar ($) Royalty amount In US$

.. ~<:;~~\J"(JX~~~ /

:;·-:~-: :2:;~~;::¥.

~ ., t::.lf'vSC·~~-~ : l ~1~;_f5,~ ~t~~

,,, . .• . .. ;f t·''a.rcnl.:i. Deolsr/:··· ~. , ...... . . c .a ,, ;:A; ct:-:c; lrXHGiJt10:oJ:

~ ... :, t·BY'.iO t,i~~;

Amount in Rs./ US $ l (Fractions were Rounded off

1 wherever required) 8A0,10,979

58,80,770

6,17,834 52,62,936

66.35

79,320.81

.. 2

Natco Pharma Limited Regd. Off. : 'NA:l'CO HOUSE', Road No. 2, Banjara Hills, Hyderabad ·· 500034.

Telangana, INDIA. Tcl : +91 40 23547532, Fax : +91 40 23548243 CIN: t24230TG19S1PLC003201, '•lvww.natcopharma.co.in

Please find enclosed the .copy of the swlft details sent as per the sender's reference no.004MISC016231316 from our Banker INDUSIND BANK LIMITED to the BANK OF NEW YORK, MELLON, PITSBURGH, PA, USA. Please also find enclosed the Chartered Accountant Certificate about the product sales made during the said period.


Thanking you,

Yours faithfully, For NATCO Pharma limited

~~ M.ADJNARAYANA COMPANY SECRETARY & VICE PRESIDENT {LEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to: (t) The Controller General of Patents, Designs and Trademarks - For favor of information Bhoudhlk Sampada Bhavan and records. Near Antop Hlfl Head Post Office, S.M.Road, Antop Hill, Mumbai- 400 037.

(ii) The Deputy Registrar Intellectual Property Appellate Board Annex-11 Guna Complex, II Floor 443, Anna Salai, Teynampet CHENNAI- 600 018.

(iii) Bayer Corporation 100, Bayer Road;, Pittsburgh, PA 15205-9741, USA.

(iv) Ra]eshwarl & Associates S-208, LowerGround Floor Near fNG Vysya Bank, Panchsheel Park NEW DELHI -110 017.




~!.'"::i'~t~fJ'~'"'"-0"""'"'"''~"="'--==:·"'"-'>""•""'~'ho<····"'~"''"'"-'·~~~"""''"'~"=o.c'C':·.,•:::;."'"-·:·e·•··~•-'"c~~'-'"''~"'-''"''"'''''"· .. -.c~.'=''"'"'"'"''''S'S':<:'"'-"~'""""'"-'OO<>O~~~"'-"-""'·"-'''''''''''"''"'"~~.:o:."•-"J'CC.O•.=""'-""'-'""'·'•"'·'·'·''""-"""'"""-="=·"'=""-"~''"'·'-'·'·""'-~~~·'"""'~u.•.~·•·•w-c~~~~'~"~··=•·-.·<e·•"·"'"•"•"''" · ,-u·J.....:~.~--""'""""-"''""'"...,_,...,, ... ,"""""'-~

--------------------- Instance Type and Transmission -------------Notification (Transmission) of Original sent to SWIFT (ACK) Network Delivery Status : Network Ack Priority/Delivery : Normal Message Input Reference : 0033 1604141NDBINBBAHYB0266125506

-------------------------- Message Header -----------------------Swift Input :FIN 103 Single Customer Credt Transfer Sender : INDBINBBHYB



MUR: M124917 -------------------------- Message Text -------------------------



32A: Val Dte/Curr/lnterbnk Settld Amt Date : 13 April2016 Currency : USD (US DOLLAR) Amount #79320,81#

50K: Ordering Customer-Name & Address /200000319957 NATCO PHARMA LIMITED NATCO HOUSE, ROAD NO 2, BANJARA HILLS HYDERABAD , INDIA

53A: Sender's Correspondent - Fl BIC /000048283 INDBINBBXXX INDUSIND BANK LIMITED MUMBAI IN

57 A: Account With Institution - Fl BIC MELNUS3PXXX

f ,. ~ \. It' L .... :._ ~

.:...~-\ > '

)~.,.. .

\

~ ~·


59: Beneficiary Customer-Name & Addr /0065525 BAYER CORPORATION 100 BAYER RD USA

70: Remittance Information ROYALTY SERVICES


--------------------------- Message Trailer-----------------------{CHK:64B5C34C2E63} PKI Signature: MAC-Equivalent

-------------------------- Interventions -------------------------Category : Network Report Creation Time: 14/04/16 00:36:07 Application :SWIFT Interface Operator : SYSTEM Text {1 :F211NDBINBBAHYB0266125506}{4:{177:1604140033}{451 :0}{1 08:M124917}}

\

,. ··,. ·~ ~. (

,\'

•. /"J:Y

/ \

YOWTHA & CO G'ARTERED ACCOUNTANTS

Hyd. Branch: Plot No. 1 767, Rd. 54, Jubilee Hills, Hyderabad - 500 033. Phone : 040-65695432 Mobile : 9849441118

Service Tox No.: AAGFK1590FST001 Email : [email protected]

Date : ................................... .


THIS IS TO CERTIFY THAT, we have certified the records of MIS. NA TCO PHARMA LIMITED, ·having its Registered Office at NATCO House, Road No.2 Banjara Hills, Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENAT 200mg Tablets 120's made by the said Company during the period of January, 2016 to March, 2016.

Based on the verification of the records, information and the explanation given by the Company, we hereby certify that the Company has made the following sales of SORAFENAT 200mg Tab l20's during the period under review.

Net Sales Made by the Company e----+-1 M_on-th __ _ +--------······ -.....---· ··-········ ··--·-·----

I

No. of Bottles Sold (120 tab. l Pack

Value in Rs. i

I 1. ' January, 2016 4998 30417023 i ~----------+-------------------+---------------------r-----~----=4

February~ 2016 3522 20795567 i 2

3 March, 2016 5432 32798389

Total 13952 84010979

The Royalty is being paid on the value or Sales made consequent to the grant of a compulsory license for manufacture of a product owned by MJs. Bayer Corporation and not on account of any technical or financial collaboration. The limits of Royalty fixed under the Income Tax Act 1 FEMA therefore, do not apply to this payment. This payment is being made on the orders of

the Intellectual Property Appellate Board.

Date ; April12, 2016 Place : Hydcrabad

For KOWTHA ,~ Co. Chartered Accountants

M. No. 202342 )<

• '"\J,t'--

"'\ ;~~~JATA ) Partner

Head Office: 26-22-21, Mudunuruvari Street, Gandhi Nagar, Vijayawado- 520 003 Phone : 0866-5563440, 0866-2573440, Fax · 0866-2570960

J j ]

1 l l l ,-----1

\v~ -~ ;~tf./ .. ~ .. ' ,.. __ ,·

Natco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Ba1~jara Hills, Hyderabad - 500034.

Telangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243 _CIN: L24230TG1981PLC003201, www.natcopharma.co.in

Bayer Corporation 100, Bayer Road, Pittsburgh, PA 15205~9741, USA. Address for Service in fndfa PERFEXIO LEGAL, 9655, Sector-C, Pocket 9, Vasant Kunj New Delhi~ 110 070.


Respected Sir,

151h July, 2016

Sub: Payment of Royalty on Net Sales of Sorafenlb made by the Company for the period April, 2016 to June, 2016- Reg.

Ref: 1. Order dated gth March 2012 of the Controller General of Patents, Design and Trademarks. 2. Intellectual Property Appellate Board Order no.45/2013ln OA/35/2012/PT/MUM dt.41h March, 2013


We have remitted the royalty amount for April, 2016 to June, 2016 as per the Bank details provided in your letter no.SKR/ASY/Appeal dt.6th September, 2012 received via electronic swift remittance on 14-Q7~2016. The royalty payment details are as f~lfows:

{i)

{ii) (In)

(lv) (v)

Particulars

Net Sales of Sorafenatfor the period April, 2016 to June, 2016 in Rupees Royalty amount as per Reference No.2 @7% in Rupees "'Withholding Tax @10.506%.on Royalty amount !n Rs. Net amount of Royalty lnln'2Thf Rupees (II) -(iii) Conversion Rate as on 14•7-~01 6 from Indian Rupees to us Dollar($) Royalty amount tn US$ \

Amount in Rs./ US$ (Fractions were Rounded off wherever required)

10,00,69,856

7,35,934 62,68,956

66.94 93,650.37

:j

\1

~.· ~ ~ w ~: § ~

l .~

\~ ;;.., .r I ·/ " ' ( .·

t

Natco Pharma Limited Regd. Off.: 'NATCO HOUSE', Road No.2, Banjara Hills, Hyderabad- 500034.

Telangana, INDIA. Tel: +91 40 23547532, Fa.-.. : +91 40 23548243 CIN: L24230TG1981PLCOOB201, www.natcopharma.co.in

--2--

Please find enclosed the copy of the swift details sent as per the sender's reference no.004MISC016243911 from our Banker INDUSIND BANK LIMITED to the BANK OF NEW YORK, MELLON, PITSBURGH, PA, USA. Please also find enclosed the Chartered Accountant Certificate about the product sales made during the said period.


Thanking you,

Yours fatthfufly, For NATCO Pharma limited

~~ M.ADINARAYANA COMPANY SECRETARY & VICE PRESIDENT (lEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to:

{i) The Controller General of Patents, Designs and Trademarks - For favor of Information Bhoudhlk Sampada Bhavan and records. Near Antop HIJI Head Post Office, S.M.Road,Antop Hill, Mumbai- 400 W7.

(ii) The Deputy Registrar Intellectual Property Appellate Board

Annex-1, Guna Complex, II Floor 443, Anna Salai, Teynampet CHENNAI· 600 018.

(iii) Sayer Corporation 100, Bayer Road, Pittsburgh, PA 15205-9741, USA.

(iv} Rajeshwarl & Associates 5-208, lower Ground Floor Near lNG Vysya Bank, PanchsheeiPark NEW DELHl-110 017.


- For favor of Information and records.


<.------------------------)~

·~ tl

] ~

~~-----1 J

_,.,. #' / .

:/~// "'-

Natco Pbarma Limited Rcgd. off. ~ 'N~O HOUSE, Ro&d No.2, &njara Hills, Hyderabad • 500034.

Telangana, tNl>lA. Tel: +91 40 23547532, Fax; +91 40 2354$243 ClN : t.24~0l'Gl9SlPLC<l0320 1, www.natcophanna.eo.in

Bayer Corporation 100, Bayer Road, Pittsburgh, PA 1S205-9741,.USA. Addrgss forht'vke in India PERF$00 LEGAL. 96551 Sector~c, Pocket 9, Vasant Kunj New Delhi· 110010,

I I(_


Respe~ed Sir,

17th October, 2016

Sub: Payme11t of Royalty on Net Sales of Sorafenlb made by the Company for the period July, 2016 to September, 2016 '":' Reg.

Ref: 1. Order dated gth March 2012 of the Controller General of Patents, Design and Trademarks. 2..lntellectual Property Appellate Board Order no.45/20B in OA/35/2012/PT/MUM dt.4t~~ March, 2013

••• Wrth referencetothe above subject we woUld Oketo state the following:

We have remltted-tn~ royalty amount for July, 2016 to September, 2016 as per the Bank details provided in your letter no.SKR/ASY/Appeal dt;Gth September,2012 received via electronic swift remittance on 14-10.2016. The royalty payment details are as follows:

Particulars Amount ht Rs./ US $ (Fractions were Rounded off wherever required)

(I) Net Sales of Sorafenatfor the period July, 2016to September, 2016 11,43;56,000 ln .R\Jp~e;s

(II) Royaltv am()unt as per Reference No.2 @7% In Rupees 80;04,920 {Iii) *\1VltbhC)Jdin2'[email protected]%'on·Roya1ty amount rn Rs. 8.40,997 (iv) Net, amount of Ro\falty in Indian Rupees Oi}- (iii) 71,63,923 M Conversion Rate as on 13-1()..2016 from indian Rupees to us Dollar($} 66.8250 (vi) Royalty am punt In us S 1,07,204.24

.. 2

0.···,·

:,: l J 1

~ ~

~--' 0.

Natco Pharma Limited l<.t!gd. Off. : ~NIJCO HOU'$E', Roud No. 2, Banjara Hill.$, Hyderabad • SOOD34.

Telan~, lNDlA.l\!1: +91 40 23547532, Fax : +9140 23548243 CTN: t2423UTG1981PLC003201, www.nateophe_rma.co.in

Please find endosed the copy of the swfft dt!tails sent as per the sender's reference no:004MISC016~6650 from our Banker INOUSINO SANK LIMITED to the BANK OF NEW YORK. MELlON, PITSBURGH. PA, USA Please also find enclosed the Chartered Accountant Certlflc;,te about the product sales made durinJthe said period.


Thanking you,

Yours faithfully, For NATCO Pharma limited

M-~AA-~ M.AOJNARAVANA<;OMPMV SECRETARY & VIC£PREStDENT {LEGAl & CORP. AFFAIRS)

Encl:a; a.

C.C.to: ll) The Controller General of Patents, Destens and Trademarks - For favor of Information and records. BhoUdblk,Sampada';Shavan Near Antop Hill Head'PostOfflc:e, s.M.Road, Antop Hill, Mumbal- 400&37.

(ii} The OeP\11-Y ~eglnrar lntelle®alPtoperty Appellate Board Annex•1. Gi.ma Complex, Jl. Floor 44~, Anna Salal, Teynampet CHENNAI- 600 '018.

{iit)~J"Catp!:iradoo, 100, Bayer ftoad, Pittsburgh, PA 1520$-9741, USA.

{iv) Raleshwarl & Associates 5-208, Lower Ground Floor NeartNGVysya Bank, PancbsbeefPark NEW DEUII· 110 017.

- For favor of information and·records.

- for favor uf information and records.

. For favor of information and records.

--------------------- Instance Type and Transmission -------------Notification (Transmission) of Original sent to SWIFT (ACK) Network Delivery Status : Network Ack Priority/Delivery : Normal Message Input Reference : 0324 1610141NDBINBBAHYB0444320797

--------------------------- Message Header -------------------------Swift Input :FIN 103 Single Customer Credt Transfer Sender : INDBINBBHYB



MUR: M133580 -------------------------- Message Text ---------------------------



32A: Val Dte/Curr/lnterbnk Settld Amt Date : 13 October 2016 Currency : USD (US DOLLAR) Amount #1 07204,24#

SOK: Ordering Customer-Name & Address /200000319957 NATCO PHARMA LIMITED NATCO HOUSE, ROAD NO 2, BANJARA HILLS HYDERABAD , INDIA



\-'-.,, ,_. '

I ",

~-\

\'

<;~(,"'~~;~~-·~·.&·"'•'"'~~,C=O~""'-~'~'"~'~~~~·~~~~=~-'=""-·'·~~'"-'·~~"-'"-"'.Jc'-'-~~""-"""OL"'""'X<•'c~o·CcC . .C<,..,uw~u.Oc'c'·''·'•.'-O·C••o,oC'"'"''-"'""-'"'"'"-C··,8C·C''' .:·o.L::c~....:..~•..:..._..;,:.::,0;.!..:.).;_\,£•::>~·0o:,'-;..;,..;.;.;o~l}_000_0_:_'t0(.\o,JL::tWc.JJ:..'..!'Jbi;;.'i<~;,.:;,,c'lf'i,_..,.-~-,':,!',.-,.,..;.-.,·.~"""'.!......_,_~..._,u.:...C;~ • .;"~'·O<il."<~,',,;;.,,!.,;.'-.!.'..'.l:o-'-•~'.."-''-~·>..:.o;.,":. .• '-,'!~·-<~~'-'•-'--".:.'-"'-'"'-'~"'-"''-'--\..·-c..:O'-.c\.'\..'."-~:.::.:.lc:£<.:."--:"=·""""-''-"'-"'n.:.u~~.;,-..;J•:J<;;.·•~..:.Q._•~Jo."-'-''':.!l...'>.:''-r.:r:._·V"~"'"'-''•''..!I.Oli...J .......... ~-~-"""""-'""'''''""''l.~;.

['


59: Beneficiary Customer-Name & Addr /0065525 BAYER CORPORATION 100 BAYER ROAD PITTSBURGH UNITED STATES OF AMERICA

70: Remittance Information TOWARDS PAYMENT OF ROYALTY


--------------------------- Message Trailer ------------------------{CHK:DDA5F970M3B} PKI Signature: MAC-Equivalent

--------------------------- Interventions ------------------------Category : Network Report Creation Time: 14/10/16 03:24:45 Application :SWIFT Interface Operator : SYSTEM Text {1 :F211NDBINBBAHYB0444320797}{4:{177:161 0140324}{451 :0}{1 08:M133580}}

~ .,, [:'

~ :~:

'' ,, ,, \

t<OWTHA & CO . C'\

Hyd Branch : Pioi No. ll6 7, Rd 54, jubiiee hills, Hyderabad - 500 033 . Phone : 040-65695432 ®lARTERED ACCOUNTANTS Mobile : 9849441118

Service Tax No.: AAGFK 1590FSTOO 1 Email : [email protected]

TO WHOI\<ISOEVER IT MAY COJ'tkERN

THIS IS TO CERTIFY THAT, we have certified the records of MIS. NATCO PHARMA

LIMITED, having its Registered Office at NATCO House, Road No.2 Banjara Hills.

Hydcrabad-500 034, with reference to the Sales of the product Sorafenib under th~ir brand

name SORAFENAT 200mg Tablets 120's & SORAFENAT 200mg Tablets 60's made by the said Company during the period of .July, 2016 to September, 2016.

Based on the verification of the records. information and the explanation given by the

Company, we hereby certify that the Company has made the follo\ving sales of SORAFENAT

200mg Tab 120's & SORAFENAT 200mg Tab 60's during the period under review .

.......... . ----······-····-------··· ___ , ...... ··············---· ....... ------------~

SI. No. l Month Net Sales Made by the Company

No. of Bottles Solt1_(_12-0-ta_b_. ~..----- ---···-----~

Value in Rs., Pack)

--·-·--·-------1---------- _. ________ _ L i July,

~ 1 .. -2-----~---

42221000 i i .

··············--r----- i

2016 6992

·····················-··--······- ··········-··-·······-·-··-·-·---- --·-······--·········· f 32391000 i : i

i August, 2016 5320 : ---------·-·-···--·-- ---·

39178000 J

113790000 :

I September, 2016 3 6477

·---+--------·····-·--···-··--····· ·------------~-! Total 18789

I No. of Bottles Sold (60's tab :

\pack) I

' 9.3 -+~------~ 283000 i

·--····--- I 186ooo :,1

it. I .July, 2016 ' ~--12 August, 2016 61

3

B

I Septembe~~ 2016

·-·----rTota 1

i

! ;

32 97000

--·····-··········-·--···------__,_ ____ _ 186

The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory

license for manufacture of a product owned by \-1/s. Bayer Corporation and not on account of

any technical or financial collaboration. The limits of Royalty fixed under the Income Tax Act

i FEMA therefore. do not apply to this payment. This payment is being made on the orders of

;,~:~tell;;~;~a:;.::rt:o:pellate Board. (~~~¢~~~'' ~:;~~::l~~~; ' Head Office: 26-22-21, Mudunuruvmi Stt~!'~BJi1fi'Jogor, Vijayowodo .FRNJ00~.1450S

Phone: 0866-5563440, 0866-25'"/Jifo, Fox· 0866-2570960

,N.atco Pbarma Limited Hegd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad . 500034.

Thlangana, INDIA.. Tcl : +91. 40 23547532, Fax.: +91 40 23548243 CIN: L242SOTG1981PLC003201, www.natcopharma..co.in

Bayer CorporatiOn 17th January, 2017 100, Bayer Road, Pittsbu"Sh# PA 15205-9741, USA Address for Service In India PE~fE}(lO L~GAl1 96SS; Sector-C, P.ocket 9, Vasant Kunj New Delhi- 110 070.

Kind Attn: Mr. Sanjay Kumar, Counsel for tpe Patentee

Respected Sir,

Sub: Paymentof ~oyalty on Net Sales of Sorafenib made by the Company for the period October, 2016 to December,.2016- Reg.

Ref. 1. Order dated gth March 2012 of the Controller General of Patents, Design and Trademarks. 2.1ntellectual Property.Appellate Board Order no.45/20l31n OA/35/2012/PT/MUM dt.4'" March, 2013

"'*"' With reference to the above subJect we would like to state the following:

We have remitted the royalty amount for October, 2016 to December, 2016 as per the Bank details provided ln your letter no.SKR/ASY/Appeal dt.6th September, 2012 received via electronic swift remittance on.12-01·2017. The royalty payment detalls are as follows:

(i)

(iil iii) hl) v)

(vi:}

Partlet~l~rs Amount In Rs./ US$ (Fractions were Rounded off wherever required)

Net Sales.ofSorafenat for the period October, 2016 to 14,os,n,G96 December, 20~_61n Rupees Royalty arnounfas per Reference No.2 @7% fin Rupees) 98,61,439

--·· *Withholding Tax @10.506% on Ro:talty amount In Rs. .. i 10,36,043 Net amount of Rova:tty Itt lndlan Rupe!:!s {ii)- {iii) \ 88,25,396 Conversion Rate as on 12,.01-2017 from Indian Rupees to US Dollar($) 68.0350 I

Royalty amount ln US$ 1,29,718.47

§-~' ;: ,•'' . ; ~ '("

i~(J; • .!.l> 1!

'~ f.;:'.l. •t

,:;

Natco Pharma Limited lregd. Off. : 'N.KT:CO HOUSE', Road No. 2. Banjura Hills, Hvderabad • 500034.

Telangana, INDIA. Tel; +9140 23547532, Fax: -l-9i 40 23548243 CIN :.:L24230TG 1981 PLC003201. l-vww.natcopharma.co.in

-2--

Please find enclosed the copy of the swift details sent as per the sender's reference no·004MJSC0:17271658 from our Banl<er INOUSINO BANK UMITEO to the BANK OF NEW YORK, MEllON, PlTSBURGH, PA1 USA. Please also find enclosed the Chartered Accountant Certificate about the product sales made during the said period.

Kindlyact<nowledse the ~!pt of the same.

Thanking you,

Yours faithfully, F.orNATCO'Pharma limited

AkAJ'l;.>i~~"'-"'"-~ M.AOINARAYANA COMPANY SECRETAf\:'N~. VICE PRESIDENT {lEGAl & CORP. AFFAIRS)

end; a. a.

CC.to: (i) The Contl:DIIer General of Patents, Designs and Trademarks· For favor of information and records. Bhoudl:ltkSampada·Bhavan NearAotop Hill Head Post Offlcei S;NJ.Roadi Mtop Hill, · Mumbai .. 406037.

(II) The: Deputy Re&JStrar fntellectualProper:tyAppeltate BQard Annex.,.1; Guna Compte~. It Floor 44$'i Annasatai~ Teynampet CHENNAl· 600 03.8.

{iii} Bayer C9rporatlon lOO~'a;iy~r~~Jtst Pittsburgh/ PA 1S20$;9741;USA.

(lv) AaJeshwarl & Associates s-20Bilower'GTQl.md ffoor N~ariNG Vysya Bank, PanchsheeiPark NEW DEI.Hl-110 017~

• For favor of information and records.

- Forfavor of information and records.


--------------------- Instance Type and Transmission ------~-----Notification (Transmission) of Original sent to SWIFT (ACK) Network Delivery Status : Network Ack Priority/Delivery : Normal Message Input Reference : 02071701131NDBINBBAHYB0531419162

I ------------------------- Message Header ------------------------

Swift Input :FIN 103 Single Customer Credt Transfer Sender : INDBINBBHYB



MUR: M224424 --------------------------- Message Text ---------------------------



32A: Val Dte/Curr/lnterbnk Settld Amt Date : 12 January 2017 Currency : USD (US DOLLAR) Amount #129718,47#

50K: Ordering Customer-Name & Address /200000319957 NATCO PHARMA LIMITED NATCO HOUSE, ROAD NO 2, BANJARA HILLS HYDERABAD I INDIA



.. \

·, .


59: Beneficiary Customer-Name & Addr /006-5525 BAYER CORPORATION UNITED STATES OF AMERICA

70: Remittance Information TOWARDS ROYALDY PAYMENT


--------------------------- Message Trailer -----------------------{CHK:FCF365F13781} PKI Signature: MAC-Equivalent

---------------------------- Interventions -------------------------Category : Network Report Creation Time: 13/01/17 02:07:02 Application :SWIFT Interface Operator : SYSTEM Text {1 :F211NDBINBBAHYB0531419162}{4:{177:1701130207}{451 :0}{108:M224424}}

' \

l 1

l I j

:

KOWTHA&CO ~CHARTERED ACCOUNTANTS

· S.,rvice Tax No.; MOA<l590fSTOOl

Hyd. Branch: Plot No. 1167, Rd. 54, Jubilee Hills, Hyderabad- 500 033. Phone : 040~65695432 Mobile: 9849441118 Email : [email protected]

Dote: ................................... .


THIS IS TO CERTIFY THAT, we have certified the records ofM/S. NATCO PHARMA LIMITED, having its Registered Office at NATCO House, Road No.2 Banjara Hills, Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENAT 200mg Tablets 120's & SORAFENA T 200mg Tablets 60's made by the said Company during the period of October, 2016 to December, 2016.

Based on the verification of the records, information and the explanation given by the Company, we hereby certify that the Company has made the following sales of SORAFENA T 200mg Tab 120's &

SORAFENAT 200mg Tab 60's during the period under review.

Sl. Month Net Sales Made by the Company No.

No. of Bottles Sold (120 tab. Pack) Value in Rs.

1. October, 2016 6907 4,19,84,559

2 November, 2016 6345 3,83,15,897

3 December, 2016 9872 6,00,61 '788

A Total 23124 14,03,62,244

No. of Bottles Sold (60's tab pack)

1. October, 2016 65 1,96,748

2 November, 2016 49 1,48,811

3 December, 2016 56 1,69,893

B Total 170 5,15,452

Grand Total A+B 14,08, 77,696

The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory license for manufacture of a product owned by M/s. Bayer Corporation and not on account of any technical or financial collaboration. The limits of Royalty fixed under the Income Tax Act I FEMA therefore, do not apply to this payment. This payment is being made on the orders of the Intellectual Property Appellate Board.

Date : January 5, 2017 Place : Hyderabad


M. Mo. 202842

,, c .. ) .. 'j~ "-\ . G. SUJATA / Partner

.. ~ Natco Pharma Limited

Reg(!. Off.: 'NATCOHOUSE', Road No.2. Banjura Hills, Hyderabad- 500034. ielangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243

CIN : L24230TG 1981 PLC00320 l, www.narc.opharma.co.in

Bayer Corporation 100. Bayer Road, Pittsburgh, PA 15205~9741, USA. Address for Service in India PfRFEXIO lfGAL, 9655, Sector-C, P<><:ket 9, Vasant Kunj New Delhi- 110 070.

J<ind Attn: Mr. Sanjay Kumar, Counsel for the Patentee

Respected Sir,

171h April, 2017

Sub: Payment of Royalty on Net Sales of Sorafenlb made by the Company for t11e period January, 2017 to March,2017- Reg.

Ref: 1. Order dated 9(" March 2012 of the Controller General of Patents, Design and Trademarks. 2. fntelfectual Property Appellate Board Order no.45/2013 in OA/35/2012/PT/MUM dt.41h March, 2013

••• With reference to the above subject we would like to state the following:

We have remitted the royalty .amount for January, 2017 to March, 2017 as per the Bank details provided in your letter no;SKR/ASY/Appeal dt.61h September, 2012 received via electronic swift remittance on 13~04-2017. The royalty payment details are as follows;

Particulars ----··---r Amount in Rs./ US$ l (Fractions were Rounded off

J whercverrequired) {i) Net Sales of Sorafenat for the period January, 2017 to l 14,15,53,884

Marcil, 2017 tn Rupees {li} ~oy-alty ;~meunt ~per Reference Na._2 @7% (in R11pees) L 99,08,7?_~

(llil "'Withholding Tax @10.506% on Royalty a!!lount in Rs. ! 10,4.1,016 (tv) Net amount of Royalty in Indian Rupees (ii}- (iii) I 88,67,756

(v) Conversion Rate as on 13-04-2017 from Indian Rupees to US Dollar {~L}-- 64.31J -(vi) Royalty amount In US $ 1,37,890.78

.. 2

.... ~·'"'*"_..........-~~-··--·-·--

Natco Pharma I.Jmited Regd. Off. : 'NATCO H!?USB', Road No. 2. Banjara Hills. Hyderabad - 500034.

Tclnngana, INDIA. Tel: +91 40 23547532, Fax: +91 40 2.3548243 ClN ; 1:24230TG 1981PLC003ZO I, www.narcopbarma.eo..in

Please find enclosed the copy of the swift details sent as per the sender's reference no.0195617FTS000405 from out Banker Allahabad Bank to the BANK OF NEW YORK, MELLON, PITS BURGH, PA, USA. Please also find enclosed the 0\artered Accountant Certificate about the product sales made during the said period.

Klnd~y aclmowledge~the receipt of the same.

Thankingyou,

Yoursfalthfully, For NATCO Pharma Limited

hi:h-V~~~~c. M.AOINARAYANA COMPAN.\' SECRETARY & V.P.(LEGAL & CORP. AFFAIRS)

Enel: a. a.

C. C. to: {I) The Controller. General of Patents, Designs and Trademarks· For favor of Information and records. Shoudhik sarnpada Bhavan Near An top Hill Head Post Office, S.M.Road, Antop Hill, Mumbai • 400 037.

(ii) The Deputy Registrar lntell~al Property Appellate Board Annex•l~ Guna Complex, II Floor 443, Anna Salal, Teynampet CHENNAI- 600 018.

(iii) Bayer Corporation 100, Bayer Road,· Pittsburgh, PA 15205-9741, USA.

{iv) Rajeshwari & Associates 5-208, lower Ground Floor Near JNG Vysya Sank, Panchsheel Park NEW OELHl·llO 017.




···.BAN····:·.·.,·,K·· ··' : .. ; ;' .

. ·· .. ·.

Header Block Message Direction I - SWIFT ACKNOWLEDGEMENT Message Type 103 Messag_e Received Date 13-04-201719:15:59

Sender Detail Receiver Detail Sender ALLAINBBSIF Receiver PNBPUS3NNYC Sender Session 8212 Receiver Session

Sender Sequence 810322 Receiver Seauence

Sender Date - Time - Receiver Date - Time -Transaction Detail

Transaction Reference Number 0195617FTS000405

Value Date 170413

Currency USD

Amount 137890.78

Messa~ e Detail

:20: SENDER'S REFERENCE 0195617FTS000405

:23B: BANK OPERATION CODE CRED

:32A: VALUE DATE/CURRENCY/INTERBANK 170413USD137890, 78 SETILED AMOUNT

:33B: CURRENCY/INSTRUCTED AMOUNT USD137890 78

:SOK: ORDERING CUSTOMER /20153854992 NATCO PHARMA LTD ROAD NO 2, NATCO HOUSE HYDERABAD

:57 A: ACCOUNT WITH INSTITUTION /ABA ROUTING NO: 043000261 MELNUS3P

:59: BENEFICIARY CUSTOMER /0065525 BAYER CORPORATION 100, BAYER ROAD, PITISBURGH PA 15205-9741. USA

:70: REMITIANCE INFORMATION /ROYAL TV ON SORAFENAT 200MG

:71A: DETAILS OF CHARGES OUR

Trailer Detail D651 B63DF819

00000000

======END OF DOCUMENT======

l ~

i } )

l

l J

~ l ~ 1 .~

·!.,;

'J;

8 KOWTHA&CO CHARTERED ACCOUNTANTS

Service Tax No.: AAGFK1590FST001

~··· Hyd. Branch : Plot No. 1167; Rd. 54, Jubilee Hilfs, Hyderabad - 500 033. Phone : 040-65695432 Mobile : 9849441118 Email : [email protected]

TO WHOMSOEVER IT MAY CON(gfiRN ................................ .

TIDS IS TO CERTIFY THAT, we have certified the records of MIS. NATCO PHARMA LIMITED, having its Registered Office at NATCO House, Road No.2 Banjara Hills, Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENAT 200mg Tablets 120's & SORAFENAT 200mg Tablets 60's made by the said Company during the period of January, 2017 to March, 2017.

Based on the verification of the records, information and the explanation given by the Company, we hereby certify that the Company has made the following sales of SORAFENAT 200mg Tab 120's & SORAFENAT 200mg Tab 60's during the period under review.

SI. No. Month

1. January, 2017

2 February,2017

3 March, 2017

A Total

1. January, 2017

2 February,2017

3 March, 2017

B Total

Grand TotalA+B

Net Sales Made by the Company

No. of Bottles Sold (120 tab. Pack)

7817

6068

9335

23220

No. of Bottles Sold (60's tab pack)

132

125

225

482

Value in Rs.

47022779

36922250

56144703

140089732

400878

379595

683679

1464152 !

141553884

The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory license for manufacture of a product owned by M/s. Bayer Corporation and not on account of any technical or

financial collaboration. The limits of Royalty fixed under the Income Tax Act I FEMA therefore, do not apply to this payment. This payment is being made on the orders of the Intellectual Property Appellate

Board.

Date : Aprilll, 2017 Place : Hyderabad


Natco Pbarma Limited Regd. OfE : 'NATCO HOUSE', Road No.2. Banjara Hills, Hyderabad - 500034.

Telangana, INDIA Tel: +91 40 23547532, Fax: +91 40 23548243 CIN : L24230TG1981PLC00320 1, www.natcopharma.co.in

Bayer Corporation 100, BayerRoad, Pittsburgh, PA 15205-9741, USA. Address for Service in India PERFEXIO LEGAL,

9655, Sector-C, Pocket 9, Vasant Kunj New Delhi- 110 070.


Respected Sir,

Sub: Payment of Royalty on Net Sales of Sorafenib made by the Company for the period April, 2017 to June, 2017- Reg.

Ref: 1. Order dated gth March 2012 ofthe Controller General of Patents, Design and Trademarks. 2.1ntellectual Property Appellate Board Order no.45/2013 in OA/35/2012/PT/MUM dt.41h March, 2013


We have remitted the royalty amount for April, 2017 to June, 2017 as per the Bank details provided in your letter no.SKR/ASY/Appeal dt.61h September, 2012 received via electronic swift remittance on 13-0f-2017. The royalty payment details are as follows:

Particulars Amount in Rs. I US$ (Fractions were \

Rounded off i

········-····-·-----wherev!i:_!'r_~_quired)

{i) Net Sales of Sorafenat for the period April, 2017 to June, 2017 14,46,65,495 in Rupees

(ii} Royalty amount as per Reference No.2 @7% {in Rupees) 1,01,26,585 (iii) *Withholding Tax @10.506% on Royalty amount in Rs. 10,63,899 (iv) Net amount of Royalty in Indian Rupees (ii)- (iii) 90,62,686 (v) Conversion Rate as on 13-07-2017 from Indian Rupees to US Dollar($) 64.4450 (vi) Royalty amount in US $ 1,40,626.67

··-

.. 2

N a teo Ph arm a Limited Regd. 0~.: 'N.t\fCO HOUSE', Road No.2, Banjara Hills, Hyderabad. 500034.

Tel.mgana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243 CIN : L24230TG1981I'LC003201, www.natcopharma.co.in

--2--

Please find enclosed the copy of the swift details sent as per the sender's reference no.ORM0004170032032 from our Banker lnduslnd Bank to the Bank of New York, Mellon, Pitsburgh, PA, USA. Please also find enclosed the Chartered Accountant Certificate about the product sales made during the said period.


Thanking you,


~ COMPANY SECRETARY & V.P.(LEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to: (i) The Controller General of Patents, Designs and Trademarks - For favor of information and records.

Bhoudhik Sampada Bhavan Near Antop Hill Head Post Office,

S.M.Road, Antop Hill, Mumbai- 400 037.

(ii) The Deputy Registrar Intellectual Property Appellate Board

Annex-1, GunaComplex, II Floor

443, Anna Salai, Teynampet CHENNAI- 600018.

(iii} Bayer Corporation 100, Bayer Road, Pittsburgh,

PA 15205-9741, USA.

(iv} Rajeshwari & Associates S-208, Lower Ground Floor

Near INGVysya Bank, PanchsheeiPark NEW DELHI -110 017.




rJf'J~o~~Cil><JiJ.;dol~u;-l""';"<·~i;,;,~<;;;·i>t~_.~,_.,,.;:_,.~~!~-tNt><>WS,,"'-'-"·'·;'''-"'·"L••"·•···-'·'·--•- -·

i ~ '

SWIFT DETAILS MT103 SINGLE CUSTOMER CREDIT TRANSFER TO INSTITUTION MRMDUS33:XXXX PRIORITYN :20: SENDER'S REFERENCE ORM0004170032032 :23B: BANK OPERATION CODE CRED

' ,,

· :32A: VALUE DATE/CURRENCY/INTERBANK SETTLED AMOUNT 170713USD140626,67 :50K: ORDERING CUSTOMER 111080131 NATCO PHARMA LIMITED NATCO HOUSE ROAD NO 2 BANJARA HILLS HYDERABAD ANDHRA PRADESH INDIA :52A: ORDERING INSTITUTION INDBINBBHYB INDUSIND BANK LIMITED (HYDERABAD, S.P. ROAD) HYDERABAD INDIA HYDERABAD :53B: SENDER'S CORRESPONDENT /000048283 :57 A: ACCOUNT WITH INSTITUTION MELNUS3P:XXX THE BANK OF NEW YORK MELLON NULL PITTSBURGH,PA UNITED STATES OF AMERICA PITTSBURGH,PA :59: BENEFICIARY CUSTOMER /006-5525 BAYER CORPORATION UNITED STATES OF AMERICA :70: REMITTANCE INFORMATION ROYALTY PAYMENT :71A: DETAILS OF CHARGES SHA

• - '_<' 'i ,.- ~ ·, .c/

Bayer Corporation 100, Bayer Road, Pittsburgh, PA 15205-9741, USA. Address for Service In lnd Ia PERFEXIOLEGAL, 9655, Sector-C. Pocket 9, Vasant Kunj New Delhi- 110 070.

Natco I)harma Limited Reg{L Off. : N.:~.:rr;o HOtS£', Rom:l No. 2. Bunjan. IIiik llvderabad- 500034

1t:LngaxJ;,, INOlA lei : -~~n 40 231>475;3<.:, ht.X: ~9l 40 23548243 C!N : L24230TG l9B J Pi Cnn:1201. www.n<>tt:oph<1rtnil.cc.iu

( 13t~ October, 2017

i<;'ind Attn: Mr. Sanlav Kumar, Cc.PJnspl for the :>C~tente~

~espected Sir,

Sub: Payment of Royalty on Net Sales of Sorafenib made by the Company for the period July, 2017 to September, 2.017- Reg.

Ref: 1. Order dated 9111 March 2012 of the Controller General of Patents, Design and Trademarks. 2. Intellectual Property Appellate Board Order no.45/20B in OA/35/2012iPT/MUM dt.41

h March, 2013

* '"" With reference to the above subject we would !ike to state the following:

We have remitted the roy1:1lty amount for July, 2.017 to September, 2017 as per the Bank details provided in your letter no.SKR/ASY I Appeal dt.6th September, 2012 via electronic swift rem itt a nee on 12-10-2017. The royalty payment details are as follows:

Particulars

(I) Net Sales. of Sor-afenat for the period July, 2017 to

....... - .. ]"'Amount in Rs./ us s (Fractions were Rounded off wherever required) I "' "' ....... ------..... ·---·-·--·"·«-- ... - ---·j

17,66,05,335 1

____ September~~017 in R_l...clp_e~e_s ___ _ {.!!) Royalty amount as pe~~fer~l_1~1!_~_o.2 @7% {in Rupees) 1,23,62,373 1

(iii) *Withholding Tax @10.506% on Royalty amount in Rs. ..·---=--~?-:!~8,?9~-! ., (iv)--N~tamountofRoyaltyinlndianRu·p~;~{i"ij~-~iiiJ ·- - , ---- ·-- 1,10,63,582 i j {v) Conversion Rate-ason-12:1Q~2oi7--iiom Indian Rupees to us '----------- 5s.i1Sl

Gvtl· ~~=~~~~~i~!J-~t .... -· .. ·--·--- --- --··· ---t 1,69,908.35 I

,{::f£::.~.-Y'' ·· \·~ · ···,···,"·: .:. , ,_ !,•{:;.,;.:~·;;;~~ ... -i•;;:.;,L..:.~".t..~~~~6i:.r;._.".;i<r,o.wr.:.;::.r."~)':<:!:<.H:::".'~·If~,;.:-'-..:"':.,..~."'-'~""'"'~~--'-··- ·

J

Regd. IJ(L. !1-:ATCO f!Ot!>L. Rm1tl f\1L) lLmi:lr:! l!n\s. :i•;derabati SiHHB-1. 1f:,ianr~1n~-\~ lNDl/\ Tel : .... 91 i-O ::::,t';·.~ .... :.<52. f".t-.. -';'-~; i 4n 1~!548'1...-·~·::. .

Natco Pbarrna Lirnitcd

Cl~.J. 1.24-23(J'fGl981.!}LC003L(.'l. \\\V\V.nah:opharm(!_eo.in

--Z-·

Please find endosed the copy of the swift details sent a.s per the sender's reference no.ORM0004170064516 from our Banker lnduslnd Bank to the Bank of New York, Mellon, Pitsburgh, PA, USA. Please also find enclosed the Chartered Accountant Certificate about the product sales made during the said period.

Klridly acl<nowletrge the receipt of the saine.

Thanking you,

Your's faithfully,

For NATCO Pharma limited :(7;;~:~~1·~./:-~_;1\ -.~\.~::-rAJ." ~ .. "~;."..-t-1" r!'« . .-L,,.(_ ~ .... ' .A~:. ~ :<::::.>-\~dsraca-.):;::!1

M.AD!NARAYANA ·::~\..__ ~/'-'// COMPANY SECRETARY & ~f/ V.P.(LEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to:

(i) The Controller General of Patents, Designs and Trademarks- For favor of information and records. Bhoudhik Sampada Bhavan Near Antop Hill Head Post Office, S.M.Road, Antop Hill, Mumbai- 400 037.

(ii) The Deputy Registrar

Intellectual Property Appellate Board 1\~ne..x-l, Guna Complex, .!1 Floor 443, Anna Salai, Teynampet CHENNAI- 600 018.

(iii} Bayer Corporation 100, Bayer Road, Pittsburgh, PA 15205-9741, USA.

(iv) Rajeshwarr & Associates S<208,lower Ground Floor Near lNG Vysya Bank, Panchshee!Park NEW DELHI -110 017.

-for favor of information and records.



::! -~- .... - ..

. :1

SWIFT DETAILS MT103 SINGLE CUSTOMER CREDIT TRANSFER TO INSTITUTION MRMDUS33XXXX PRIORITYN :20: SENDER'S REFERENCE ORM0004170064516 :23B: BANK OPERATION CODE CRED :32A: VALUE DATE/CURRENCY /INTERBANK SETTLED AMOUNT 171012USD169908,35 :50K: ORDERING CUSTOMER /11080131 NATCO PHARMA LIMITED NATCO HOUSE ROAD NO 2 BANJARA HILLS HYDERABAD ANDHRA PRADESH INDIA :52A: ORDERING INSTITUTION INDBINBBHYB INDUSIND BANK LIMITED (HYDERABAD, S.P. ROAD) HYDERABAD INDIA HYDERABAD :53B: SENDER'S CORRESPONDENT /000048283 :57 A: ACCOUNT WITH INSTITUTION MELNUS3PXXX THE BANK OF NEW YORK MELLON NULL PITTSBURGH,PA UNITED STATES OF AMERICA PITTSBURGH,PA :59: BENEFICIARY CUSTOMER /006-5525 BAYER CORPORATION USA :70: REMITTANCE INFORMATION ROYALTY PAYMENT :71A: DETAILS OF CHARGES OUR

?'#"•'·'".'"';C..<;;',~i.<~""'~:;JI]j&;.----~O!~--.""'"""'""'''·'·''-·'·''''·"""'·C.'7''o.·.

I \~~ / ..

.;t

~~

I )

~

I l l 1

iPWTHA&CO CHARTERED ACCOUNTANTS GSTIN : 36AAGFK1590FlZE PAN NO. : MGFK1590F SAC : 00440092

Hyd. Branch : Plot No. ! 167, Rd 54. Jubilee Hills, Hyderobad - 500 033. Phone : 040-65695432 Mobile : 9849441 T J 8 Email : [email protected]


THIS IS TO CERTIFY THAT, we have ce1tified the records 9ftt\VS:"NATCO.'PHARMA.

LIMITED, having its Registered Office at NATCO House, Rond No:.2 Banjara Hills, Hyderabnd-

500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENA T

200mg Tablets l20's & SORAFENAT 200mg Tablets 60's made by the said Company during the period of .July, 2017 to September, 2017.

Based on the verification of the records, information and the explanation given by the Company, we

hereby certify that the Company has made the following sales of SORAFENAT 200mg Tab 120's &

SORAFENAT 200mg Tab 60's during the period under review.

j Month !

Net Sal~s Made by the -Company -·-·1

--+-No. ofBottlcs Sold (i2o tab. -~ J Value in Rs.! , Pack) ,

r-1-. -----t-j-.Ju-l-y,---2-0-17----+--------9-92-4------+-· .. --...... _58_1_1_92_8_6....,1

rr-···----+-A-ug-u-st-, -·2-0-17-···-.. - .... ---+-.. ---·- 12057 ...... 73218955]

t 3 Septembcr,2017--· .. ---+-------·69i9'-·-·~~-L 41780332- i

~. A I Total 28910 I 173118573

I No. of Bottles Sold (60's tab

1ll I July, 2017 1

pack) 429 , 11628151

i ~ ' August,-ul17 400 + i097011l

\3 September,2017 420 ~ 1n Total ==t_ 1249 I , 34867621

I Grand Total A+B i 1 176605335 '

L----~----::---:---'-----:-~----=:----:------::-::-- ·-·---· ___l. ·----The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory license

for manufacture of a product owned by M/s. Bayer Corporation and not on account of any technical or

financial collaboration. The limits of Royalty fixed under the Income Tax Act! FEMA therefort', do not

apply to this payment. This payment is being made on the orders of the Intellectual Property Appellate

Board. For KOWTHA & ,c" >·~, ·; >~ Chartered AccouP ·.;

1>>~~,. / M. No_. 2psr. i ~:{,v\,f·" f ( L\ \l;.;x.::LG\..,.

-~ "<- ....., ' , < ' l ~ t

,,',·/>,)! / \./\ G. sDJATr\ ·,~: ,l·~··' '"~} , gartoer

Date October 06,2017

Place : Hyderabad

Head Office : 26-22-21, Mudunu,~~i~d(i~Street, Gandhi Nagar, Viiay~wado- 520 003. Phone: 0866-5563440, 0866-2573440, Fox: 0866-2570960

.r'

Bayer Corporation 100, Bayer Road, Pittsburgh, PA 15205~9741, USA. Address for Service in India PERFEXIO LEGAL, 9655, Sector-C, Pocket9, Vasant Kunj New Delhi- 110 070.

,/1., ,> I · ~ r

J I

N a teo Pharn1a Liinitcd R<·;.;d. Off : "HTCO HOUSE, !had Nn. 2, Banjnra Hilh. l!y•'<er:!bad ,dUO:;.;

Tclang<mn, INDU\. 'l£! : ·cq !. 40 23547532, Pax: -+-91 ·W 23548243 Cl\'. L242:5liTG1981 PLC0032Ul, IVWW.r13tcopharm;I.U•.in

lOth January, 2018


Respected Sir,

Sub: Payment of Royalty on Net Sales of Sorafenib made by the Company for the period October, 2017 to December, 2017- Reg.

Ref: 1. Order dated gth March 2012 of the Controller General of Patents, Design and Trademarks. 2. Intellectual Property Appellate Board Order No.45/2013 in OA/35/2012/PT/MUM dt.4th March, 2013


We have remitted the royalty amount for October, 2017 to December, 2017 as per the Bank details

prov~ded in your letter no.SKR/ASY/Appeal dt.61" September, 2012 via electronic swift remittance on

09.01.2018. The royalty payment details are as follows:

[

--·--... -.. ·-·-. ----·.-------.- Partic1..dars -----r~:~~;~~~~~/. ~!~ndedl

1 off wherever required) --l

'I ci)--Net Sal~s. of s~~af~~~t-f;;;-th~ period October, 2017 to i 20,70,99,423 i December, 2017in Rupees _,_. __ ........... - ............ ,. __ .__ --· . .... __l

I (ii) Royaltyamountas per Reference No.2 @7% (in Rupees) ! 1,44,96,960 I

.Ji}!L ... *Withholding Tax @10.506% oi1'RQYarty ... amountin-Rs~·-- ·---~~-=~·- -~==~~~=~~- 15,23,05~ (iv) Netamount of Royalty in Indian Rupee$ (ii}- (j~iL.. j ~!3~73~909 (v) ConveJsion R\'lte as on 09.01.2018 from Indian Rupees to US :

l

Dollar($) I 63.50

(vi) Royalty amount in us S ----.. -=:--=~·~ .. ]=.====:.. -i04,3ii53-

WI:Y~2.:i.t.''fJ!i~~~~~:-!:.~':U'!'~..rt~~~~~'-'·'I'·A-<1~~-"H-'··.,_.; __ _

,.~-----,"~ ~~,

l

_-" "-----~-··--·

/(.1 ~ ~-~ :- I ~·

~

I 1 1 i

• . I

.Natco Pharn1a Liruited Re,d O!f o 'NArco HOUSP, Rv;oo '" 2, B'"lf•co !!ilk H)·d,,,,,,. ><Jor• ''·

Td,gena I'D lA. Yfri · > 9 I 40 23517 5:.2, Ia• ' , 9! 4<1 23540243 CJ\•: L2-~23fJTGt%il'LCoo::s:~o:t \-vwt<·.n;Jtcxlpharm;'-<'o.ir;

--2--

Please find enclOSed the copy of the swih details sent as per the sender's reference nO.ORMOIJ041B009BS:t6 f<om ou1 Banke< IMusind Bank to the Bank of New Yo<k, Mellon, Pitsbu>gh, PA, USA, Please a/so find enclosed the Cha~te<ed Acrouotant Cenmc"e about the P<oduor sales made during the said Period.


Thanking you,

Yours faithfully,

For NATCO Pharma limited

I. . \ . ~- < • -~<( '\:::+,. ,, ?~:..t"']·' ·-M.ADINARAYANA COMPANY SECRETARY & V.P.(lEGAL & CORP. AFFAIRS)

Encl: a. a.

C. C. to:

(I) !be Controller Gene~a/ of Patents, Designs and T<adema~ks - For favor of information and records. Bhoudhik Sampada Bhavan Near Antop Hill Head Post Office, S.M.Road, Antop Hill, Mumbai- 400 037.

(li) The Deputy Registrar

lnteltectttalProperty Appellate Board Annex,l, Guna Complex, II Floor 443, Anna Sa/ai, Teynampet CHENNAI- 600 018.

(iii) Bayer Corporation

·100, Bayer Road, Pittsburgh, PA 15205-9741, USA.

(iv) Ra}eshwari & Associates S-208, Lower Ground ·Floor Near lNG Vysya Bank, Panchsheel Park NEW DELHI -110017 .

.. . .... ... ····--~ ....... __ _

- For favor of Information and records.

. For favor of information and records.


. A-e

:S.W!fT I!U<\Il S

MTID3 Sll\OLL CUS1UMER CRI.D!T !i?_.t,\i:';FU~

TO INSTtTtrrro~ Ml\\:DIJS:11.\\:X); PRIORiTY~

2fi. Si'>--:DER':i RFFEI\ENCL: DR,\1Ui!V41 K!!OV;;i~"l :.:m B,\N!-: Oi'I:::RAnu;-.: COOL

\'KEP

·J:::A V\U T DAri·:L'URRl'SCY'L"iTI;'iW \1\K SE'f'f'U D A~miJ,-..:'1 iROI09l'S[);!(HJ L'-53

:~tlK ORDl'RlNG CUSTO~U:R !1()80 t::; I

N:ATCO PllAlt'YIA U\IITED NAfT:o HOUSE ROAD :-<0 2lL\Nj,\Rt\ fllU.\ IIYDERAE:lAJ) ANDHRA PRM>FSH !ND!:\ 52A: O!mt:rHNG !NSTI'n;·nm;

!NDBll\BlJHYU !NDUSi!'D HANK 1.1\-ll!TD t!tYDEf0\BAD. \.1' Rur\D: HYDEK.-\H/\D tr-.TJIA !I Y DER,\BA [)

531!· S[f..!DER'S CORRESPO>d)Ehi .iO<)th)4S2&3

.57;\. ACCOUNT \\'IT!! iNSTITl.!TIC•.'-i \·1fiLN!JS3PXXX

n IE fUNK OF NF\\ 'r'ORK MElLO!\: NULt Pf'fi'SBUR{iii.PA liNlTE!) STAITS OF A!I1EH1Ct\ Pi!T~BUROH,PA

''I UI!NEFK'IARY CUSTO\[ER /OOA-552 5

HA YEH CORP!.llt-\f'JON

100 Bt\Y!J{ RO.'\D f'IlTSBI'IWll PA l52t15·97~! US.·\ . 70./WMITTANCE INFORMATION ROYALTY CHARGES

7JA Dl'T'JLS OF CffARGFS OUR

-·,'

·. ~· ;_. '. ·.: ;_::: ::::::\; ··.·.

/

I

(__ ;/ .

lnduslnd Bank

. 'I ·-I'

~.,.;. /' '·

~ ;/

KOWTHA&CO B h. P' t·' 1 ' - 7 ')d. 5 ' Hyd. ranc : 101 '10. 1 16, ~ . - "·

Jubilee Hills, Hyderabod- 500 033. Phone : 040-65695432 CHARTERED ACCOUNTANTS

GSTIN ~ 36AAGFKl590FlZE Mobiie : 9849441118 Email : [email protected] PAN NO. : AAGFK1590F

SAC : 00440092

Dote: ...................... .......... ..

TO \VHOMSOEVER IT MAY CONCERN

THIS IS TO CERTIFY THAT, we have certified the records of MIS. NATCO PHARMA LIMITED, having its Registered Office at NATCO House, Road No.2 Banjnra Hills, Hyderabad-500 034, with reference to the Sales of the product Sorafenib under their brand name SORAFENAT

200mg Tablets 120's, SOR.<\.FENAT 200mg Tablets 60's & SORAFENAT 200mg Tablets 30's ·made by the said Company during the period of October, 2017 to December, 2017.

Based on the verification of the records, information and the explanation given by the Company. we

hereby certify that the Company has made the following sales of SORAFENAT 200mg Tab 120's,

SORAFENAT 200mg Tab 60's & SORA FEN AT 200mg Tablets 30's during the period under . review.

I Month

! '

I October, 2017

I Nt.•t Sales Mad7bYthe Company -----1 I No. of Bottles Sold (120's Tab.l 1

1 I Value in R11. l

I ~;;:: 1 _ : --r- i 64245885 i

• 8869 ----t-53885081 1

..... _, ____ ,

2 November, 2017

:3 December, 2017 --------i4o4s ss23s.ii2 1

33528 203366388 1 ~ Total I ' I I •

l

~ . October, 2017

1 No. of Botti" Sold (60'' Tab 1 - j

-t~--4o:f ______ · usJ !

--~···"-

·2

3

-433

332

1206968 i I !---------!

893221 i =iNovember,2017 -.-

1

•. ---·

December, 2017 _

f.---· . -------1----- ------·---r----· I 1168 3290128 1 . ! Total

._J..__ ____ J B

.... 2

Head Office: 26-22-21, Mudunuruvari Street, Gondh1 Hcgot, Vii~yov1oda- 520 003. Phone: 0866-5563440, 0866-2573440, Fax: 0866-:2570960

··,, ···-::. •.· ..

'.·~~·~'::,"_.:_C:: . ..:i.~.~-_;~~~i'<J;.:Ir.Jr),.,r.~'l'iW'..k.~~J•~•.'!:~_,:';,":,.'.•'.!.(~~~IfO-<:I'J~~~,O"~~;'..t2!-~'~~~~;';"~.r'0~,>":.;0;1.;':~~~':'~~;.t~'-,\~:."'l.~~·,•<,.v~'~..<'.!r'!;'~W.~;..:(!:.::•C·I•' •

~i

~

KOWTHA&CO CHARTERED ACCOUNTANTS GSTIN : 36AAGFK 1590Fl ZE PAN NO. : AAGFK1590F SAC : 00440092

! 1. October, 20.17

i2 November! 2017 I

13 I ~ecmbcr, 201~ lc

Total

I Grand Total A+B+C

I. J. ' ..

Hyd. Branch : Plot No 7 16 7. Rd S·i. Jubilee Hills, Hyderobad- 500 033 Phone : 040-65695432 Mobile : 9849441118 Email : [email protected]

Date· ............... .

I No. ~)fBottles Soid-(30's Tab i j pack)

()

----~ 25

260 !

·t·-· .. - ... -.... _, ______ .. _ ! 285

I I

I ·--... -..

0.00!

-~ 402621 1

I --~-----------~

442907 i I

-------------------~~----2070994231 The Royalty is being paid on the value of Sales made consequent to the grant of a compulsory license tor manufacture of a product owned by M/s. Bayer Corporation and not on account of any technical or financial collaboration. The limits of Royalty fixed under the Income Tax Act I FEMA therefore, do not

apply to this payment. This payment is being made on the orders of the Intellectual Property Appellate

Board.

Date : January 09~ 2018 Place : Hyderabad

F=or KOWTHA & Co Chartered Account<:Jnts

M. No 2S2842 " h \P-

C \.;,•l1·-' "':) . \ G. SUJATJ';

Portner

Head Office: 26-22-2 T, Mudunuruvari Street, Gandhi Nagar, Vijayowada- 520 003 Phone ; 0866-5563440, 0866-2573440, Fax • 0866-2570960

FORM27 THE PATENTS ACT, 1970

(39 OF 1970) &

The Patents Rules, 2003 STATEMENT REGARDING THE WORKING OF THE PATENTED INVENTION ON

COMMERCIAL SCALE IN INDIA [Sec section 146{2) and rule 131 (l)J

In the matter of Patent No. 215758;

We, NATCO PHARMA UMITED, an Indian company registered under Indian Companies Act 1956, having register~d oftice at "Natcc Hol!se", Road No.2, Banjara Hills, Hyderabad 500 034, lndia, the licensee under Patent No.215758 hereby furnish the following statement regarding referred to above on a commercial scale in India for the Calendar year ending 2016.

(i) The Patented invention: {.J} Worked{} Not worked [Tick (.J) mark the relevant box]

(a) if not worked: reason tbr not working and steps being taken for working of the invention: NA

(b) ifworked: quantum and value (in Rupees), of the patented product: Quantum: Formulati(m (INDIA Market)- 8673180 Tahlets Value: The product has a business of around Rs.4378.52/akhsfor INDIA Market in addition 124440 Tablets were provided to 608 patients free of cost.

i) manufactured in India: Yes ii) Imported from other countries (give country wise details): NA

(ii) the licenses and sub licenses granted during the year: Nil, however, Compulsory licence was granted to Natco Pharma by the Controller General of Patents, Vide Ref.No.J/2011 dated 9th March 2012.

(iii)state whether public requirement has been met partly/adequately/to the fullest extent at reasonable price.

Public requirementz's being met at reasonable price.

The facts and matters stated above are true to the best of my/our knowledge, information and belief.

Dated this March 22, 2017

Signature .~..al.>· M.Adinarayana

Company Secretary and Vice President (Legal & Corporate Affairs) Natco Pharma Limited,

Natco House~ Road No.2, Banjara Hills, Hyderabad 500 034.

cj ·l ·i .I

··)

H)RcYJ 2"' iHI·-P,\Tl-:N!S.:\1 ]_ ;c1n

!39 OF !970! &

THE PATlXlS RULLS. :;:::rr:. ~TATF:'\IE:'<.'T REGAHDIV, TI-H: \\'ORKr..:r, or THI: i'An:YTTD

ll\VF:!\TIO\' U:\ COvD-JERCL\L \C \U l"' 1"\DL\

(St.•t '''t:ti•>.ll \46 (2l and rule L'! (l '!

In 1hc mancr ilf

F<Jt<-n! ~n 21 S :-'58;

.\ = \.,~t.. __ ·,.· p;1drn1,: L.IL:il:.:d ~ ~1n !;,~:t.~.: .... q1 :p.:!h [·~l!\ in~: 1

2 L3mr_ura Hi:i.>. l!!dt:rabad 51JU ,; ;.:. in.:i,t.t';~:. f i.,·:;·,~, L

1

i i<J\\ ing :-tarcm~:nt r·c,~;u Jing lh1: ~\ "r f.-in~· ,)j !h;: f\i; ~·nl~;,: "' ·, vr' l!i)i\ rc: >''Tt:d ~<> ,~[,, ., r: '-Hi il r;ntniJ1t'n., iai s..:tde in lmlia for the :yeur cruHn:,: 201£.,

(i)

(c)

The pal.cnted invemi;>;;

1/! Worked

! i!

T/;f! product has l:wsincxs of aramul r"vR 2631J .;s !o/;},5 j(,r liYDJA Marker <·ovcrin~ 164.50 paricnts 1265 units proritf<'d IP 6 ·13 JWiir•nt.~ f(,r_ti·ee.

,\JL, howe~'er c<~mpu!sorr liu:nse wrn ;;ranted w .\me:> I'/Jarmr1 Limited u11 cyr, .\[arch ::uu

State whclhcr Public !'1cqui! ~.:'nwnt h;,-, ht.•;.:n m~:; p . .on!.\ · adc·q il<:t'.?h '•' th: lul k'>i ,. \tcut a1 re'"''mto~hic pri,·e:

Public requirement i.v hebT!J mer

(O!llpHD) ~ecrctf·lr\ ;\l:.::i \'1(:.,· Pn::-.!dt:n1 !! ~:L:;d (\. c~.)rp:·r~Ht: .;\Cf:·t:r~: \..a1-~:~~ Pharrna l..:1nit'--·,~.

'\atcu h(•Us~. Rum! no 2 BanJ;H'" Hd\c .. Hyden:bad :;oo 01,:

$-4

* +

%

IN THE HIGH COURT OF DELHI AT NEW DELHI

W.P.(C) 5590/2015

SHAMNAD BASHEER Through:

versus

UNION OF INDIA & ORS Through:

CORAM:

..... Petitioner Mr. Abhimanyu Bhandari with Mr. N. Sai Vinod and Ms. Roohina Dua, Advs.

..... Respondent Mr. Amit Mahajan, CGSC forUOI. Mr. Sanjoy Ghose, ASC with Ms. Urvi Mohan, Adv. forGNCTD. Ms. Pritha Srikumar with Ms. Neha Mathen, Advs. for intervener. .

HON'BLE THE ACTING CHIEF JUSTICE . HON'BLE MR. JUSTICE C.HARI SHANKAR

ORDER 10.01.2018

1. This writ petition highlights glaring non-compliance with the

provisions of the Patents Act, 1970 on the part the Controller

General of Patents. Inter alia, our attention is drawn to the scheme

of the enactment and the object of issuance of patents as is

manifested from Section 83 (b), (d) and (g) of the Patents Act,

1970 which deserves to be considered in extenso and read thus:

"83. General principles applicable to working of patented inventions.-

(a)xxx XXX XXX

~vt$ ____ ,..,... .. ,,-.. ·-·-

., .. :

(b} that they are not granted merely to enable patentees to enjoy a monopoly for the importation of the patented article;

(c}xxx XXX XXX

(d) that patents granted do not impede protection of public health and nutrition and should act as instrument to promote public interest specially in sectors of vital importance for socio-economic and technological development of India;

(e}xxx

(f}xxx

XXX

XXX

XXX

XXX

(g) that patents are granted to make the benefit of the patented invention available at reasonably affordable prices to the public. ''

2. Mr. Abhimanyu Bhandari, ld. counsel for the petitioner

submits that the grant of patents results in the patentees getting

exclusive rights over the inventions and therefore, it is imperative

that the Controller General of Patents maintains a scrutiny as to

whether the patent is being worked or not. To ensure that the

patentees have not merely acquired rights over the invention and

are actually working the same, the statutory scheme requires a

patentee to submit periodic information. In this regard, Section

146 of the Patents Act, 1970 empowers the Controller General of

Patents, Designs, Trademarks and Geographical Indications to call

for information in a format prescribed in accordance with Rule 131 of

the Patents Rules, 2003. The manner in which the information has to

be submitted has been set out in Form-27 annexed to the Patents

,. , >A.

'

Rules, 2003. Failure to comply with the statutory requirements

invites penalties and criminal action prescribed under Section 122

of the statute which includes imposition of fme as well as initiation

of criminal proceedings.

3. Our attention is drawn to several admissions to the effect

that the respondents are not ensuring compliance with the

requirements of Sectio·n 146 of the Patents Act, 1970 and, despite

failure of the patentees to conform to the requirements of Rule 131

of the Patents Rules, 2003 and Forrn-27, no action at all has been·

taken under Section 122 of the Patents Act, 1970.

4. In this regard, our attention is draWn. to the Annual Report

2012-13 submitted by the Office of the Controller General of

Patents, Designs, Trademarks and Geographical Indications. We

extract relevant portions of this Report wherein the following

disclosure is contained:

"(i) Working of Patents (Under Section 146): The Patent Office received 27946 Form-27 during the reporting year, of which 6201 were shown to be working.

2009- 2010- 2011- 2012-10 11 12 13

Patents 37334 39594 39989 43920 in force Form-27 24009 34112 27825 27946 received Reported 4189 6777 7431 6201" as working

5. A bare glance of the above would show that. despite the

~--------·-

~ ( -'-... _ .

1

Controller General of Patents, Designs, Trademarks and

Geographical Indications having issued 43920 patents during the

year 2012-13, returns as prescribed under Form-27 has been

received only in 27946 cases; and, shockingly, the disclosure is

only of 6201 patents as being worked by the patentees.

6. The petitioner appears to have addressed a query under the

Right to Information Act, 2005 seeking information as to the action

taken against the patentees/licensees in case of non-submission of

Form-27 .. The respondents have responded to the query on

09.01.2014 stating that no action has been initiated for non

submission ofForm-27.

7. The second glaring instance of non-compliance with the

statutory scheme of the Patents Act, 1970 is highlighted by the

petitioner in respect of grant of , a compulsory licence to M/s

NATCO Pharma in relation to patent no.215758 by order dated 9th

March, 2012 in C.L.A. No.1 of 2011 under Section 84 of the

Patents Act.

It is pointed out that the order dated 91h March, 20 12

imposed an obligation on NATCO Pharma in Para 15(b) thereof, to

report accounts of sales to the Controller on a quarterly basis, on or

before the 15th of each succeeding month.

8. By the RTI query dated 19th January, 2015, the petitioner

sought inter alia information as to whether Mls NA TCO Pharma

had complied with the above condition imposed in para 15(b) ~f

the order dated 9th March, 2012. The petitioner also queried the

Controller Gen~ral of Patents, Designs, Trademarks and

~-~\~ ("f( I (_ 7

~

i . .]

J I --

. -, :.~

' t-. (7 .. t -~ '' <. •• ~

f ~ ~ I f

Geographical Indications regarding the action in case M/s NATCO

Pharma had failed to comply with the said requirements. . th

9. In its response dated 6 February, 2015, the Patent Office

informed the petitioner that as per its records "no details are

available".

10. Our attention is also drawn to yet another statutory non

compliance. Ld. counsel for the petitioner also points out that

Section 146(2) read with Rule 131 of the Patents Act, 1970 makes

it mandatory even upon licensees to submit Form-27 containing

information on commercial working of the patented invention.

Section 146 of the Patents Act, 1970 draws no distinction between

the original patentees ·and license holders. Thus, it has been

pointed out by the petitioner that license holders are also required

to file the same information in Form-27 as a patentee.

11. Vide the response dated 1ih March, 2014, the Controller of

Patents & Designs, CPIO has informed the petitioner to the effect

that "Form-27 are filed by Patentee only". There is certainly

substance in the objection of the petitioner that this position is

contrary to the statutory requirement.

12. Ld. counsel for the petitioner has also submitted that the

respondents are not taking any action for notional or incomplete

compliance with the provisions of Section 146 of the Act. In this

regard, an instance has ·been pointed out wherein Form-27 was

submitted by M/s Telefonaktiebolaget LM Ericsson (Pub.) in

respect of patent no.203034 of 24th August, 1999. Against the

column wherein the patentee was required to disclose information

~~0

I l 1 1

l )

~

' - ., ij . ..

_,·._ ...... /-,.~ ..: :;__. l!i..,l

-e.;._~t'!r

regarding "the licenses and sub-licenses granted during the year",

this patentee stated a8 follows:

13.

"As all the licenses are confidential in nature, the details pertaining to the same shall be provided under specific directions from the Patent Office. "

It is pointed out that so far as the grant of patents are

concerned, information in regard thereto is available on the website ·

of the Patents Office. All that the patentees submitting Form-27

are required to submit,· is the details of the licenses and sub

licenses. This information certainly cannot .be termed

"confidential" and therefore, the Patents Office has to treat such

suppression as failure to comply with the requirements of Section

146 of the Patents Act, 1970 arid to take action against the

patentees who do not furnish the required information.

14. Ms. Pritha Srikumar, Advocate for the intervener has

submitted that the petitioner has also pointed out that Form-27

itself was extremely vague and the same deserves a relook by the

respondents. Mr. Srikumar would, therefore, contend that non

compliance of such form cannot be faulted with.

15. In our view, this submission is erroneous inasmuch as there

can be no exemption from statutory compliance and that in case

any query in Form-27 could not be complied with, the person

submitting the return would be required to state so. So far as the

submission that Form-27 deserves a relook is concerned, we find

that in the counter affidavit, the official respondents have stated

that they had issued a Notification dated 26th October, 2015 for a

proposed draft amendment of the Rules by "The Patents

(Amendment) Rules, 2015". The respondel).ts have also submitted

that the· san1e included amendments to Form-27 and the same has

been posted on the official website of the Department of Industrial

Policy and ·Promotion (DIPP). The counter affidavit says that

public comments have been invited.

16. This counter affidavit was filed on 7th December, 2015. We

are not informed as to what is the fate of the public notice issued by

the respondents or amendments to the said Rules. Mr. Amit

Mahajan, ld. CGSC is unable to inform this Court as to whether the

necessary amendments have been effected to Form-27.

1 7. This writ petition has remained pending in this Court since .

2015. We also do not have any information as to whether there is

any change in the status with regard to the filing of returns under

Section 146 of the Patents Act, 1970 and whether any action taken

by the Controller Ge~eral of Patents and Designs under Section

122 of the Act.

18. Mr. Amit Mahajan, ld. CGSC prays for an adjournment to

inform this Court with regard to the status of the amendment of the

rules and the action taken under Section 122 of the Patent~ Act,

1970.

On his request, list on 18th January, 2018.

Natco Pharma Limited - SpicyIP

Documents